duloxetine hydrochloride has been researched along with Dyskinesia Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Memon, NA; Shanker, R; Siddiqui, SH | 1 |
| Hao, A; Hideyama, T; Sato, T; Shibuya, H; Shiio, Y; Tsujimoto, Y | 1 |
2 other study(ies) available for duloxetine hydrochloride and Dyskinesia Syndromes
| Article | Year |
|---|---|
Drug-induced movement disorder and confusion associated with duloxetine.
Topics: Antidepressive Agents; Brain; Confusion; Depressive Disorder, Major; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Movement Disorders | 2018 |
[Anti-Hu antibody positive sensory neuronopathy causing painful legs and moving toes (PLMT) in a 75-year-old female with small cell lung cancer (SCLC)].
Topics: Aged; Antineoplastic Agents; Ataxia; Autoantibodies; Duloxetine Hydrochloride; ELAV Proteins; Female; Humans; Immunoglobulins, Intravenous; Leg; Lung Neoplasms; Movement Disorders; Pain; Paraneoplastic Polyneuropathy; Paraneoplastic Syndromes; Paresthesia; Small Cell Lung Carcinoma; Toes | 2018 |